Multiple sclerosis treatment cost in Austria runs from $200 to $300 for a consultation with an ophthalmologist, while specialized treatments like Ocrevus (ocrelizumab) range from $35,000 to $45,000. Total expenses depend on the disease stage, specific medication protocols, and the need for intensive rehabilitation. Austria offers approximately 20-40% savings compared to the United States. Top cities for MS management include Vienna and Lassnitzhoehe.
Typical Multiple Sclerosis Treatment Costs in Austria
Bookimed Expert Insight: Patients requiring complex therapy benefit from specialists like Professor Fritz Leutmezer at Wiener Privatklinik. His expertise in shaping European MS treatment standards ensures high-level diagnostic accuracy. For intensive recovery, Private Hospital Lassnitzhöhe is ideal. Its ISO-certified neurological rehabilitation facility features 289 beds and an indoor pool. Vienna General Hospital (AKH) offers immense clinical resources with its "city in a city" concept.
| Turkey | Austria | Spain | |
| Plasmapheresis | from $1,200 | from $2,000 | from $1,800 |
| Ocrevus (ocrelizumab) | from $10,000 | from $35,000 | from $25,000 |
| Multiple sclerosis rehabilitation | from $3,000 | from $10,000 | from $10,000 |
| Medication treatment for multiple sclerosis | from $2,500 | from $2,000 | from $3,000 |
Professor Fritz Leutmezer has contributed to European MS treatment guidelines and led clinical trials shaping modern therapy standards at Wiener Privatklinik.
Dr. Natalia Hauser specializes in the diagnosis and treatment of Multiple sclerosis at Döbling Private Hospital.
Dr. Fritz Leutmezer leads Austria's Multiple Sclerosis Society and has published 60+ neurology papers. He treats MS at Vienna General Hospital.
Dr. Klaus Novak is a neurosurgeon in Vienna with over 20 years of experience. He graduated from the University of Vienna in 1992. He became a board-certified neurosurgeon in 2001. He completed international training. This included research at Beth Israel Hospital in the United States. He introduced intraoperative motor evoked potential monitoring in Austria.
His clinical focus includes spine surgery, brain tumors, hydrocephalus, epilepsy, movement disorders, and neuromodulation. He is active in the interdisciplinary Movement Disorder Board at MedUni Vienna.